Ignite Creation Date:
2024-05-06 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03602391
Status:
COMPLETED
Last Update Posted:
2023-10-06
First Post:
2018-07-06
Brief Title:
The Senior Companion Program Plus
Sponsor:
The University of Texas at Arlington
Organization:
The University of Texas at Arlington
Study Overview
Official Title:
The Senior Companion Program Plus SCP Plus A Psychoeducational Intervention for African American Dementia Caregivers
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SCP Plus
Brief Summary:
Alzheimers disease and related dementia ADRD is one of the most challenging chronic health conditions in the United States and considerable disparities exist in the diagnosis and prevalence of ADRD among communities of color Research suggests that ADRD caregiver interventions have demonstrated efficacy however it remains unknown whether existing ADRD caregiver interventions are useful or accessible to African American ADRD caregivers in community settings
The primary goal of the proposed project is to develop an in-home psychoeducational intervention The Senior Companion Program Plus or SCP Plus that is accessible sustainable and affordable for African American ADRD caregivers The SCP Plus will focus on African American ADRD caregivers who are particularly affected by poverty discrimination and barriers to health care services and supports A recent pilot study has established the feasibility and utility of SCP Plus With the assistance of 6 student research assistants over the course of the project we will implement the SCP Plus at sites in Texas Louisiana and Arkansas recruiting approximately 114 participants The participants will be randomized with 57 caregivers receiving the SCP Plus and 57 caregivers receiving services as usual with the Senior Companion Program A weekly 60 minute psychoeducational module will be delivered face-to-face across 9 weeks and will focus on education about ADRD behavior management communication skills and aspects of providing care that enhance meaning such as spirituality In order to provide an accessible and cost effective intervention that is potentially sustainable senior companions will be trained to provide the intervention in the homes of the African American ADRD caregivers
Specific Aim 1 Determine whether SCP Plus reduces level of burden and stress among African American caregivers over a 3- and 6-month period when compared to a usual care control group
Specific Aim 2 Ascertain if SCP Plus improves coping skills among African American caregivers over a 3- and 6-month period when compared to a usual care control group
Specific Aim 3 Examine whether SCP Plus improves the level of satisfaction with support social among African American caregivers over a 3- and 6- month period when compared to a usual care control group
Specific Aim 4 Explore and interpret the statistical results obtained in the first quantitative phase to help explain why participants who scored in the lower and upper quartiles on caregiver burdenstress were impacted or not by the usefulness of the intervention
Successful design delivery and evaluation of the SCP Plus will lead to a cost effective sustainable and accessible intervention that can be implemented in other Senior Companion programs across the country thus maximizing its impact as a community-based program to address the needs of African American ADRD caregivers
The primary goal of the proposed project is to develop an in-home psychoeducational intervention The Senior Companion Program Plus or SCP Plus that is accessible sustainable and affordable for African American ADRD caregivers The SCP Plus will focus on African American ADRD caregivers who are particularly affected by poverty discrimination and barriers to health care services and supports A recent pilot study has established the feasibility and utility of SCP Plus With the assistance of 6 student research assistants over the course of the project we will implement the SCP Plus at sites in Texas Louisiana and Arkansas recruiting approximately 114 participants The participants will be randomized with 57 caregivers receiving the SCP Plus and 57 caregivers receiving services as usual with the Senior Companion Program A weekly 60 minute psychoeducational module will be delivered face-to-face across 9 weeks and will focus on education about ADRD behavior management communication skills and aspects of providing care that enhance meaning such as spirituality In order to provide an accessible and cost effective intervention that is potentially sustainable senior companions will be trained to provide the intervention in the homes of the African American ADRD caregivers
Specific Aim 1 Determine whether SCP Plus reduces level of burden and stress among African American caregivers over a 3- and 6-month period when compared to a usual care control group
Specific Aim 2 Ascertain if SCP Plus improves coping skills among African American caregivers over a 3- and 6-month period when compared to a usual care control group
Specific Aim 3 Examine whether SCP Plus improves the level of satisfaction with support social among African American caregivers over a 3- and 6- month period when compared to a usual care control group
Specific Aim 4 Explore and interpret the statistical results obtained in the first quantitative phase to help explain why participants who scored in the lower and upper quartiles on caregiver burdenstress were impacted or not by the usefulness of the intervention
Successful design delivery and evaluation of the SCP Plus will lead to a cost effective sustainable and accessible intervention that can be implemented in other Senior Companion programs across the country thus maximizing its impact as a community-based program to address the needs of African American ADRD caregivers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None